Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Simian immunodeficiency virus | 14 | 2011 | 846 | 1.360 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 10 | 2011 | 570 | 1.110 |
Why?
|
| Macaca mulatta | 16 | 2011 | 2375 | 0.880 |
Why?
|
| CD4-Positive T-Lymphocytes | 9 | 2011 | 4386 | 0.580 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 2 | 2011 | 307 | 0.450 |
Why?
|
| Adenoviridae | 4 | 2010 | 1099 | 0.450 |
Why?
|
| Immunologic Memory | 7 | 2010 | 1348 | 0.440 |
Why?
|
| Immunization, Secondary | 6 | 2010 | 340 | 0.430 |
Why?
|
| SAIDS Vaccines | 3 | 2008 | 166 | 0.410 |
Why?
|
| Vaccines, Synthetic | 4 | 2010 | 634 | 0.390 |
Why?
|
| CD8-Positive T-Lymphocytes | 8 | 2011 | 4479 | 0.350 |
Why?
|
| Viral Vaccines | 2 | 2009 | 636 | 0.280 |
Why?
|
| Virus Replication | 5 | 2010 | 2534 | 0.260 |
Why?
|
| Lymphocyte Subsets | 1 | 2006 | 315 | 0.260 |
Why?
|
| T-Lymphocytes | 3 | 2009 | 10180 | 0.220 |
Why?
|
| Immunologic Techniques | 1 | 2003 | 218 | 0.220 |
Why?
|
| HIV-1 | 4 | 2010 | 6939 | 0.200 |
Why?
|
| Interleukin-2 | 2 | 2006 | 1904 | 0.200 |
Why?
|
| HIV | 2 | 2007 | 1604 | 0.200 |
Why?
|
| Genetic Vectors | 6 | 2010 | 3420 | 0.190 |
Why?
|
| AIDS Vaccines | 4 | 2010 | 938 | 0.190 |
Why?
|
| Lymphocyte Activation | 2 | 2009 | 5524 | 0.170 |
Why?
|
| Interferon-gamma | 6 | 2008 | 3206 | 0.170 |
Why?
|
| Gene Products, gag | 4 | 2009 | 337 | 0.170 |
Why?
|
| RNA, Viral | 7 | 2009 | 2902 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2008 | 4420 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3870 | 0.090 |
Why?
|
| Adenoviruses, Simian | 1 | 2009 | 14 | 0.090 |
Why?
|
| Animals | 17 | 2011 | 168757 | 0.080 |
Why?
|
| Mycobacterium bovis | 1 | 2009 | 150 | 0.080 |
Why?
|
| Chimera | 1 | 2009 | 485 | 0.080 |
Why?
|
| Measles virus | 1 | 2007 | 68 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2007 | 1838 | 0.080 |
Why?
|
| Measles Vaccine | 1 | 2007 | 76 | 0.080 |
Why?
|
| Mucous Membrane | 1 | 2011 | 673 | 0.080 |
Why?
|
| Poxviridae | 1 | 2007 | 37 | 0.080 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2009 | 2559 | 0.070 |
Why?
|
| Immunity, Mucosal | 1 | 2010 | 490 | 0.070 |
Why?
|
| Flow Cytometry | 2 | 2011 | 5974 | 0.070 |
Why?
|
| Immunity, Cellular | 3 | 2009 | 1607 | 0.070 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2009 | 370 | 0.070 |
Why?
|
| BCG Vaccine | 1 | 2009 | 369 | 0.070 |
Why?
|
| Receptors, IgG | 1 | 2009 | 582 | 0.070 |
Why?
|
| Cytokines | 3 | 2010 | 7322 | 0.070 |
Why?
|
| Measles | 1 | 2007 | 168 | 0.070 |
Why?
|
| Vaccinia virus | 1 | 2007 | 349 | 0.070 |
Why?
|
| Viral Load | 3 | 2009 | 3299 | 0.060 |
Why?
|
| Immunization | 1 | 2009 | 1256 | 0.060 |
Why?
|
| Vaccines, DNA | 1 | 2006 | 305 | 0.060 |
Why?
|
| Cell Count | 1 | 2008 | 1856 | 0.060 |
Why?
|
| HIV Infections | 3 | 2009 | 16718 | 0.060 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2003 | 329 | 0.050 |
Why?
|
| HLA-A2 Antigen | 1 | 2003 | 213 | 0.050 |
Why?
|
| Chromium | 1 | 2003 | 123 | 0.050 |
Why?
|
| HIV Long-Term Survivors | 1 | 2003 | 126 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2011 | 2133 | 0.050 |
Why?
|
| HIV Antigens | 1 | 2003 | 347 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2009 | 2232 | 0.050 |
Why?
|
| Monocytes | 1 | 2009 | 2596 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2006 | 2373 | 0.040 |
Why?
|
| Antibodies, Viral | 4 | 2011 | 3176 | 0.040 |
Why?
|
| Granzymes | 2 | 2008 | 271 | 0.030 |
Why?
|
| Vaccination | 1 | 2007 | 3278 | 0.030 |
Why?
|
| Haplorhini | 1 | 2011 | 552 | 0.020 |
Why?
|
| Titrimetry | 1 | 2009 | 36 | 0.020 |
Why?
|
| Gene Products, pol | 1 | 2009 | 47 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 2009 | 229 | 0.020 |
Why?
|
| Gene Products, env | 1 | 2009 | 263 | 0.020 |
Why?
|
| Adenoviruses, Human | 1 | 2009 | 257 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 14722 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2009 | 758 | 0.020 |
Why?
|
| Viral Envelope Proteins | 1 | 2011 | 635 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2008 | 644 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2009 | 1588 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2008 | 40561 | 0.020 |
Why?
|
| Humans | 6 | 2011 | 744343 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 1157 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2006 | 880 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2009 | 19229 | 0.010 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 1978 | 0.010 |
Why?
|
| Plasmids | 1 | 2006 | 2307 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2006 | 1072 | 0.010 |
Why?
|
| Alleles | 1 | 2011 | 6933 | 0.010 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 12072 | 0.010 |
Why?
|
| Cell Communication | 1 | 2006 | 1621 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2011 | 5021 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 13815 | 0.010 |
Why?
|
| Peptides | 1 | 2006 | 4409 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 9146 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2006 | 10252 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 18111 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 18029 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 13284 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 40075 | 0.010 |
Why?
|
Concepts
(94)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_